These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 1667936
1. Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis have an increased capability to release tumour necrosis factor during peritonitis. Fieren MW, van den Bemd GJ, Bonta IL, Ben-Efraim S. J Clin Lab Immunol; 1991 Jan; 34(1):1-9. PubMed ID: 1667936 [Abstract] [Full Text] [Related]
2. Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood. Enríquez J, Klínger J, Arturo JA, Delgado M, Tobar C, Mosquera M. Adv Perit Dial; 2002 Jan; 18():177-83. PubMed ID: 12402614 [Abstract] [Full Text] [Related]
3. Peritoneal macrophages from patients on CAPD show an increased capacity to secrete interleukin-1 beta during peritonitis. Fieren MW, van den Bemd GJ, Bonta IL. Adv Perit Dial; 1990 Jan; 6():120-2. PubMed ID: 1982787 [Abstract] [Full Text] [Related]
4. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship. Carozzi S, Nasini MG, Ravera M, Sanna A, Tirotta A, Lamperi S. Adv Perit Dial; 1997 Jan; 13():7-12. PubMed ID: 9360642 [Abstract] [Full Text] [Related]
5. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis. Zemel D, Struijk DG, Dinkla C, Stolk LM, ten Berge IJ, Krediet RT. J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393 [Abstract] [Full Text] [Related]
6. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. Zemel D, Koomen GC, Hart AA, ten Berge IJ, Struijk DG, Krediet RT. J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688 [Abstract] [Full Text] [Related]
7. Cytokines and peritonitis in continuous ambulatory peritoneal dialysis: immunodeviation and immunodeficiency. Klínger J, Enríquez J, Arturo JA, Delgado M, Avila G, Ceballos O. Adv Perit Dial; 2002 Dec; 18():170-6. PubMed ID: 12402613 [Abstract] [Full Text] [Related]
8. Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation. Zemel D, Krediet RT, Koomen GC, Kortekaas WM, Geertzen HG, ten Berge RJ. Nephrol Dial Transplant; 1994 Dec; 9(2):169-74. PubMed ID: 8190331 [Abstract] [Full Text] [Related]
9. Serial peritoneal macrophage function studies in CAPD patients with peritonitis. Lin CY, Huang TP. Adv Perit Dial; 1990 Dec; 6():114-9. PubMed ID: 1982786 [Abstract] [Full Text] [Related]
10. Advanced glycation end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous ambulatory peritoneal dialysis. Rashid G, Korzets Z, Bernheim J. Isr Med Assoc J; 2006 Jan; 8(1):36-9. PubMed ID: 16450750 [Abstract] [Full Text] [Related]
11. Lipopolysaccharide binding protein: a marker for intraperitoneal bacterial infection in patients with CAPD peritonitis. Schäfer K, Schumann RR, Stöteknuel S, Böhler J, Schollmeyer P, Dobos GJ. Adv Perit Dial; 1997 Jan; 13():210-3. PubMed ID: 9360683 [Abstract] [Full Text] [Related]
12. IL-4 suppresses IL-1 beta, TNF-alpha and PGE2 production by human peritoneal macrophages. Hart PH, Cooper RL, Finlay-Jones JJ. Immunology; 1991 Mar; 72(3):344-9. PubMed ID: 2026443 [Abstract] [Full Text] [Related]
13. Prostaglandin E2 inhibits the release of tumor necrosis factor-alpha, rather than interleukin 1 beta, from human macrophages. Fieren MW, van den Bemd GJ, Ben-Efraim S, Bonta IL. Immunol Lett; 1992 Jan; 31(1):85-90. PubMed ID: 1548034 [Abstract] [Full Text] [Related]